Early-Stage Technology Header image

Early-Stage Technology Assessment for SMEs

Be confident in your investment decisions - evaluate the commercial potential of healthcare technology in development through the IHE Early-Stage Life Sciences Technology Assessment service.

The IHE provides services for early-stage small- and medium-sized enterprise (SME) technology developers (or other innovators, such as an academic group considering forming an SME) to present important insights into the potential for commercial success. This includes an assessment of the health economic evidentiary requirements and hurdles that will need to be met and overcome to market a technology that is attractive to payers. Insights from IHE services will support decision-making on the merits of further product development or modifications in design to improve the value offering, and will assist with raising capital.

IHE Early-Stage Life Sciences Technology Assessment:

Early Stage Assessment image

Key Benefits

  • Save time, money, and intellectual resources by identifying technologies that are unlikely to be commercially successful.
  • Understand how to design or adjust an R&D/evidence development program to increase the likelihood of commercial success.
  • Obtain a robust assessment of commercial potential for use in raising capital and increasing resources available to the organization.

The IHE is your independent, not-for-profit, critical ally

A lot is riding on the decisions you make. If you represent a company with a life sciences technology in development, or an organization that supports or funds these companies, let us provide you with the evidence you need to support your decision-making.

Be confident in what comes next. Contact us to better understand how our technology assessment service can support your organization.

For more information about IHE service offerings to support life sciences SMEs, including potential sources of funding, please contact us at innovation@ihe.ca.


Downloads